Carleton Ltd. today announced the introduction of Bon Optic Vitreal® S, a new Triamcinolone formulation for use in endocular surgery without preservatives
VITREAL® S is for used in endocular surgery to stain the vitreous body during vitrectomy. The micro particles of Triamcinolone cause the vitreous humour to become opaque and make it easier to remove. VITREAL® S is a new formulation containing tramcinolone acetonide 4% without preservatives and a saline buffer. The new formulation of VITREAL® S, compared to the previous version, does not contain the carbopol. VITREAL® S is CE marked medical device and is available in a 2ml vial containing 8 mg of triamcinolone acetonide.
For more clinical information regarding the use of VITREAL® S during vitrectomy or to order please contact Carleton Ltd. on (01494) 775811.
